289 related articles for article (PubMed ID: 8501153)
21. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
22. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
[TBL] [Abstract][Full Text] [Related]
23. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
[TBL] [Abstract][Full Text] [Related]
24. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
[TBL] [Abstract][Full Text] [Related]
25. Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a).
Laron Z; Wang XL; Klinger B; Silbergeld A; Wilcken DE
Eur J Endocrinol; 1997 Apr; 136(4):377-81. PubMed ID: 9150696
[TBL] [Abstract][Full Text] [Related]
26. Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome.
Lieberman SA; Butterfield GE; Harrison D; Hoffman AR
J Clin Endocrinol Metab; 1994 Feb; 78(2):404-10. PubMed ID: 7508949
[TBL] [Abstract][Full Text] [Related]
27. Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol.
Massa G; Bouillon R; Vanderschueren-Lodeweyckx M
J Clin Endocrinol Metab; 1992 Nov; 75(5):1298-302. PubMed ID: 1430092
[TBL] [Abstract][Full Text] [Related]
28. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
29. Final height in patients with idiopathic short stature and high growth hormone responses to stimulation tests.
Martinelli CE; Sader Milani S; Previato JK; Figueira M; Rangel Montenegro AP; Miraki-Moud F; Betancourth S; Moreira AC; Savage MO; Camacho-Hübner C
Horm Res; 2007; 67(5):224-30. PubMed ID: 17135759
[TBL] [Abstract][Full Text] [Related]
30. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study.
Nunez SB; Municchi G; Barnes KM; Rose SR
J Clin Endocrinol Metab; 1996 May; 81(5):1927-32. PubMed ID: 8626859
[TBL] [Abstract][Full Text] [Related]
31. The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children.
Bussières L; Souberbielle JC; Pinto G; Adan L; Noel M; Brauner R
Clin Endocrinol (Oxf); 2000 Jun; 52(6):735-9. PubMed ID: 10848878
[TBL] [Abstract][Full Text] [Related]
32. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
33. Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-I.
Longo N; Singh R; Griffin LD; Langley SD; Parks JS; Elsas LJ
J Clin Endocrinol Metab; 1994 Sep; 79(3):799-805. PubMed ID: 8077364
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the IGF system in 15 patients with Alström syndrome.
Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A
Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998
[TBL] [Abstract][Full Text] [Related]
35. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men.
Taaffe DR; Pruitt L; Reim J; Hintz RL; Butterfield G; Hoffman AR; Marcus R
J Clin Endocrinol Metab; 1994 Nov; 79(5):1361-6. PubMed ID: 7525633
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children.
Ali A; Hashim R; Khan FA; Sattar A; Ijaz A; Manzoor SM; Younas M
J Ayub Med Coll Abbottabad; 2009; 21(3):40-5. PubMed ID: 20929010
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
38. Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children.
Achermann JC; Brook CG; Robinson IC; Matthews DR; Hindmarsh PC
Clin Endocrinol (Oxf); 1999 Mar; 50(3):301-8. PubMed ID: 10435054
[TBL] [Abstract][Full Text] [Related]
39. Assessment of growth hormone insulin like growth factor-I axis in Down's syndrome.
Barreca A; Rasore Quartino A; Acutis MS; Ponzani P; Damonte G; Miani E; Balestra V; Giordano G; Minuto F
J Endocrinol Invest; 1994 Jun; 17(6):431-6. PubMed ID: 7930388
[TBL] [Abstract][Full Text] [Related]
40. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]